Angelina Andreyevna Chernova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Angelina Andreyevna Chernova has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Valentin Elievich Oleynikov
Penza State University
9 shared publications - Lyudmila I. Salyamova
Therapy Department, Penza State University, 40, Krasnaya St., 440026 Penza, Russia
5 shared publications - Natalia A. Donetskaya
Penza State University; Burdenko Penza Regional Clinical Hospital
5 shared publications - Olga Dmitrievna Vershinina
Penza State University
5 shared publications - Alexander V. Vdovkin
Burdenko Penza Regional Clinical Hospital
3 shared publications - I. A. Babkina
Penza State University
3 shared publications
Latest Publications
- Open Access
- 2 May 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (4) , 231-236
Clinical and diagnostic significance of extracellular volume in different periods of left ventricular myocardial infarction. A review
This review examines the pathophysiological processes affecting the Extracellular Volume (ECV) in both the acute and chronic phases of myocardial infarction. It discusses how the constellation of acute myocardial injuries leads to ECV expansion, establishing it as a robust and independent predictor of adverse left ventricular remodeling, major adverse cardiovascular events, and arrhythmic risk. The review outlines current methodologies for ECV assessment. It is shown that despite limitations related to its non-specific nature and the need for protocol standardization, ECV mapping surpasses traditional approaches in infarct size quantification and risk stratification, paving the way for personalized monitoring of treatment efficacy. The review encompasses foundational validation studies as well as recent research focused on the pathophysiological rationale of the method, technical aspects of its implementation, and clinical applications of ECV analysis, including its role in evaluating anti-remodeling therapies.
- 2 May 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (4) , 231-236
Open AccessClinical and diagnostic significance of extracellular volume in different periods of left ventricular myocardial infarction. A review
This review examines the pathophysiological processes affecting the Extracellular Volume (ECV) in both the acute and chronic phases of myocardial infarction. It discusses how the constellation of acute myocardial injuries leads to ECV expansion, establishing it as a robust and independent predictor of adverse left ventricular remodeling, major adverse cardiovascular events, and arrhythmic risk. The review outlines current methodologies for ECV assessment. It is shown that despite limitations related to its non-specific nature and the need for protocol standardization, ECV mapping surpasses traditional approaches in infarct size quantification and risk stratification, paving the way for personalized monitoring of treatment efficacy. The review encompasses foundational validation studies as well as recent research focused on the pathophysiological rationale of the method, technical aspects of its implementation, and clinical applications of ECV analysis, including its role in evaluating anti-remodeling therapies.
- 29 March 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (2)
Impact of reperfusion timing and methods on myocardial structure and function in ST-segment elevation myocardial infarction
Aim. To compare the effectiveness of primary percutaneous coronary intervention (PPCI) and a pharmacoinvasive strategy (PIs) for revascularization, and to study the impact of their timing on the morphofunctional and electrophysiological myocardial characteristics in patients with ST-segment elevation myocardial infarction. Material and methods. A total of 185 patients aged 53±9 years were included. On days 7-10, patients underwent cardiac magnetic resonance imaging (MRI), speckletracking echocardiography, and Holter monitoring. Results. Subjects were divided into following groups: the early reperfusion (ER) group included 97 patients with an onset-to-revascularization time ≲180 minutes; and the delayed reperfusion (DR) group included 88 patients with an onset-to-revascularization time >180 minutes. According to MRI, scar tissue mass in the DR group was 24,7 (13,6; 42,9) g versus 15,9 (5,9; 30,7) g in the ER group (p=0,003). In the ER group, a more pronounced proportion of the heterogeneous area relative to the scar was observed compared to the DR group (p=0,018). The global contrast index in the ER group was 17,7 (10,3; 33,1)%, and in the DR group — 25 (16,2; 38,2)% (p=0,014). According to the echocardiography, lower values of global work efficiency with a simultaneous increase in global wasted work were revealed in the DR group (p180 min is associated with the most unfavorable characteristics of ischemic injury according to MRI, myocardial work according to speckle-tracking echocardiography, and Holter monitoring data. A comparative analysis of patients with PPCI and PIs performed in the first 180 minutes did not demonstrate differences in morphofunctional and electrophysiological myocardial characteristics.
- 29 March 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (2)
Impact of reperfusion timing and methods on myocardial structure and function in ST-segment elevation myocardial infarction
Aim. To compare the effectiveness of primary percutaneous coronary intervention (PPCI) and a pharmacoinvasive strategy (PIs) for revascularization, and to study the impact of their timing on the morphofunctional and electrophysiological myocardial characteristics in patients with ST-segment elevation myocardial infarction. Material and methods. A total of 185 patients aged 53±9 years were included. On days 7-10, patients underwent cardiac magnetic resonance imaging (MRI), speckletracking echocardiography, and Holter monitoring. Results. Subjects were divided into following groups: the early reperfusion (ER) group included 97 patients with an onset-to-revascularization time ≲180 minutes; and the delayed reperfusion (DR) group included 88 patients with an onset-to-revascularization time >180 minutes. According to MRI, scar tissue mass in the DR group was 24,7 (13,6; 42,9) g versus 15,9 (5,9; 30,7) g in the ER group (p=0,003). In the ER group, a more pronounced proportion of the heterogeneous area relative to the scar was observed compared to the DR group (p=0,018). The global contrast index in the ER group was 17,7 (10,3; 33,1)%, and in the DR group — 25 (16,2; 38,2)% (p=0,014). According to the echocardiography, lower values of global work efficiency with a simultaneous increase in global wasted work were revealed in the DR group (p180 min is associated with the most unfavorable characteristics of ischemic injury according to MRI, myocardial work according to speckle-tracking echocardiography, and Holter monitoring data. A comparative analysis of patients with PPCI and PIs performed in the first 180 minutes did not demonstrate differences in morphofunctional and electrophysiological myocardial characteristics.
- 8 September 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (4) , 348-359
Chronic heart failure with preserved ejection fraction after myocardial infarction: are beta-antagonists necessary? A two-year prospective study
BACKGROUND: Advances in the diagnosis and treatment of myocardial infarction have triggered an ≥50% increase in the proportion of patients with preserved left ventricular ejection fraction. The relevance of using adrenergic beta-antagonists in this patient cohort remains a topic of active debate. AIM: To study the two-year catamnesis of patients suffering from myocardial infarction with chronic heart failure and preserved left ventricular ejection fraction who either received or did not receive adrenergic beta-antagonists. METHODS: The study encompassed 127 patients with myocardial infarction aged 53 (48; 60) years with preserved left ventricular ejection fraction. On days 4–9 of myocardial infarction and on its 12- and 24-month anniversary, echocardiography with assessment of global longitudinal strain, longitudinal electrocardiogram monitoring, measurement of N-terminal natriuretic hormone peptide concentration, and a 6-minute walk test were performed. The endpoint was chronic heart failure progression over subsequent 2 years. RESULTS: The adrenergic beta-antagonist group included 98 patients (77%) who received adrenergic beta-antagonist therapy, whereas the remaining 29 patients (23%) who did not receive such therapy due to hypotension and bradycardia made up the no adrenergic beta-antagonist group. In the adrenergic beta-antagonist group, by the second year of the post-infarction period, there was an increase in the indexed values of end-diastolic and end-systolic volumes, a decrease in left ventricular ejection fraction by 3.1% (р = 0.00077) and global longitudinal strain by 2.4% (р = 0.0002); in the other group, these parameters remained flat. In patients of the adrenergic beta-antagonist group, a decrease in chronotropic load on the myocardium and an increase in the circadian index while maintaining its rigid level were recorded; in the no adrenergic beta-antagonist group of patients, an increase in chronotropic load and normalization of the circadian heart rhythm profile were observed as early as by the 12th month of observation. The number of patients with progressive chronic heart failure over 2 years of observation in both groups did not differ: 21% and 24%, respectively (the risk ratio is 0.659; the 95% confidence interval is 0.35–1.243). CONCLUSION: In today’s context, with the use of reperfusion methods for treating patients with myocardial infarction, it is necessary to conduct large-scale randomized clinical trials studying the effect of adrenergic beta-antagonist therapy on the prognosis in patients with preserved left ventricular ejection fraction. According to the results of this study, no significant differences were found in the frequency of progression of chronic heart failure in groups of patients who had suffered myocardial infarction and preserved left ventricular ejection fraction. In the group of patients who did not receive adrenergic beta-antagonists, more stable myocardial volume and deformation characteristics were observed within 24 months of myocardial infarction.
- 8 September 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (4) , 348-359
Chronic heart failure with preserved ejection fraction after myocardial infarction: are beta-antagonists necessary? A two-year prospective study
BACKGROUND: Advances in the diagnosis and treatment of myocardial infarction have triggered an ≥50% increase in the proportion of patients with preserved left ventricular ejection fraction. The relevance of using adrenergic beta-antagonists in this patient cohort remains a topic of active debate. AIM: To study the two-year catamnesis of patients suffering from myocardial infarction with chronic heart failure and preserved left ventricular ejection fraction who either received or did not receive adrenergic beta-antagonists. METHODS: The study encompassed 127 patients with myocardial infarction aged 53 (48; 60) years with preserved left ventricular ejection fraction. On days 4–9 of myocardial infarction and on its 12- and 24-month anniversary, echocardiography with assessment of global longitudinal strain, longitudinal electrocardiogram monitoring, measurement of N-terminal natriuretic hormone peptide concentration, and a 6-minute walk test were performed. The endpoint was chronic heart failure progression over subsequent 2 years. RESULTS: The adrenergic beta-antagonist group included 98 patients (77%) who received adrenergic beta-antagonist therapy, whereas the remaining 29 patients (23%) who did not receive such therapy due to hypotension and bradycardia made up the no adrenergic beta-antagonist group. In the adrenergic beta-antagonist group, by the second year of the post-infarction period, there was an increase in the indexed values of end-diastolic and end-systolic volumes, a decrease in left ventricular ejection fraction by 3.1% (р = 0.00077) and global longitudinal strain by 2.4% (р = 0.0002); in the other group, these parameters remained flat. In patients of the adrenergic beta-antagonist group, a decrease in chronotropic load on the myocardium and an increase in the circadian index while maintaining its rigid level were recorded; in the no adrenergic beta-antagonist group of patients, an increase in chronotropic load and normalization of the circadian heart rhythm profile were observed as early as by the 12th month of observation. The number of patients with progressive chronic heart failure over 2 years of observation in both groups did not differ: 21% and 24%, respectively (the risk ratio is 0.659; the 95% confidence interval is 0.35–1.243). CONCLUSION: In today’s context, with the use of reperfusion methods for treating patients with myocardial infarction, it is necessary to conduct large-scale randomized clinical trials studying the effect of adrenergic beta-antagonist therapy on the prognosis in patients with preserved left ventricular ejection fraction. According to the results of this study, no significant differences were found in the frequency of progression of chronic heart failure in groups of patients who had suffered myocardial infarction and preserved left ventricular ejection fraction. In the group of patients who did not receive adrenergic beta-antagonists, more stable myocardial volume and deformation characteristics were observed within 24 months of myocardial infarction.
- Open Access
- 8 May 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (04) , 360-366
Spatial vector cardiography: From origins to the present day. A review
Vectorcardiography (VCG) originated back in 1887 due to the discovery of the dipole theory of the heart electric vector by Augustus D. Waller. Despite the fact that the idea of constructing an electric vector of the heart quickly gained appreciation among scientists of that time, the technical imperfections of electrocardiographs and the complexity of manual calculations for a certain period of time reduced the interest of researchers in this method. The advent of digital electrocardiographs and the development of algorithms for the automatic construction of heart vectors gave VCG a second life and allowed us to look at vector theory from a different angle. It became possible to visualize the electrical processes of the myocardium in a three-dimensional image, to calculate the parameters of the depolarization and repolarization vectors. This review summarizes the currently available ideas and research results on the study of VCG. The concepts of global electrical heterogeneity and ventricular gradient based on the vector theory of the heart are discussed. The data of numerous studies testifying to the significant prognostic and diagnostic value of the obtained parameters of VCG are presented.
- 8 May 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (04) , 360-366
Open AccessSpatial vector cardiography: From origins to the present day. A review
Vectorcardiography (VCG) originated back in 1887 due to the discovery of the dipole theory of the heart electric vector by Augustus D. Waller. Despite the fact that the idea of constructing an electric vector of the heart quickly gained appreciation among scientists of that time, the technical imperfections of electrocardiographs and the complexity of manual calculations for a certain period of time reduced the interest of researchers in this method. The advent of digital electrocardiographs and the development of algorithms for the automatic construction of heart vectors gave VCG a second life and allowed us to look at vector theory from a different angle. It became possible to visualize the electrical processes of the myocardium in a three-dimensional image, to calculate the parameters of the depolarization and repolarization vectors. This review summarizes the currently available ideas and research results on the study of VCG. The concepts of global electrical heterogeneity and ventricular gradient based on the vector theory of the heart are discussed. The data of numerous studies testifying to the significant prognostic and diagnostic value of the obtained parameters of VCG are presented.
- Open Access
- 8 November 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (1) , 4215
Complex multifactorial prediction model for life-threatening ventricular arrhythmias in patients with myocardial infarction
Комплексная модель многофакторного прогнозирования жизнеугрожающих желудочковых нарушений ритма у больных инфарктом миокарда
- 8 November 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (1) , 4215
Open AccessComplex multifactorial prediction model for life-threatening ventricular arrhythmias in patients with myocardial infarction
Комплексная модель многофакторного прогнозирования жизнеугрожающих желудочковых нарушений ритма у больных инфарктом миокарда
- Open Access
- 27 August 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (7) , 5938
Potential of predicting mildly reduced and reduced left ventricular ejection fraction in patients in the post-infarction period
Aim. To analyze ischemic and reperfusion injury characteristics, as well as myocardial performance, to identify predictors of reduced left ventricular (LV) ejection fraction (EF) Material and methods. The study included were 65 patients (age 58 (52; 60) years), who were examined on days 7-10 and after 24 weeks. Based on cardiac magnetic resonance imaging (MRI), parameters of ischemic and reperfusion injury were determined. Speckle tracking echocardiography was used to evaluate the myocardial function.Results. All 65 patients completed the study. Based on echocardiography, patients were divided into following groups: 1 — 45 people with LVEF ≥50%, 2 — 20 patients with LVEF Conclusion. Contrast-enhanced cardiac MRI and speckle tracking echocardiography are complementary methods that allow quantitative morphofunctional assessment of post-infarction cardiosclerosis and predict the development of mildly reduced and reduced LVEF in the medium term.
- 27 August 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (7) , 5938
Open AccessPotential of predicting mildly reduced and reduced left ventricular ejection fraction in patients in the post-infarction period
Aim. To analyze ischemic and reperfusion injury characteristics, as well as myocardial performance, to identify predictors of reduced left ventricular (LV) ejection fraction (EF) Material and methods. The study included were 65 patients (age 58 (52; 60) years), who were examined on days 7-10 and after 24 weeks. Based on cardiac magnetic resonance imaging (MRI), parameters of ischemic and reperfusion injury were determined. Speckle tracking echocardiography was used to evaluate the myocardial function.Results. All 65 patients completed the study. Based on echocardiography, patients were divided into following groups: 1 — 45 people with LVEF ≥50%, 2 — 20 patients with LVEF Conclusion. Contrast-enhanced cardiac MRI and speckle tracking echocardiography are complementary methods that allow quantitative morphofunctional assessment of post-infarction cardiosclerosis and predict the development of mildly reduced and reduced LVEF in the medium term.
- 30 July 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
ОСОБЕННОСТИ ГИПЕРТОНИЧЕСКОЙ БОЛЕЗНИ У БЕРЕМЕННЫХ ЖЕНЩИН (ОБЗОР ЛИТЕРАТУРЫ)
Статья посвящена литературным данным об особенностях развития гипертонической болезни у беременных женщин. Около 11% случаев развития артериальной гипертонии верифицируется в группе беременных женщин. Клинические варианты артериальной гипертензии при беременности включают артериальную гипертензию, имевшуюся до беременности (хроническая артериальная гипертензия — гипертоническая болезнь или симптоматическая артериальная гипертензия), гестационную артериальную гипертонию, хроническую артериальную гипертензию, осложненную преэклампсией, и преэклампсию/эклампсию. Наиболее грозное осложнение гипертонической болезни у беременных – преэклампсия. В статье представлена классификация преэклампсии, принципы диагностики, профилактики и лечения этого осложнения. В статье так же отражены критерии классификации тяжести преэклампсии, возможность использования биохимических маркеров, с целью своевременного выявления рисков данного осложнения беременности, ранней профилактики, а так же обоснованного и адекватного лечения. Следует учитывать влияние преэклампсии на дальнейшую жизнь и здоровье женщины, так как доказано, что перенесенное осложнение беременности (преэклампсия) способствует, провоцирует или утяжеляет существующие ранее заболевания сердца и сосудов у матери и ребенка в будущем. Этим, в том числе, обусловлена немаловажная роль диспансерного наблюдения за беременными женщинами с артериальной гипертонией. Точной этиопатогенетической картины преэклампсии до сих пор нет, наиболее жизнеспособной является плацентарная теория развития преэклампсии, определяемая распространенным вазоспазмом, развитием эндотелиального воспаления и дисфункцией, а также прогрессирующей полиорганной недостаточностью. Несомненно, важной задачей остается своевременная диагностика, правильное лечении и предупреждение осложнений артериальной гипертензии у беременных. Показана необходимость и важность дальнейшего исследования этиологических факторов развития преэклампсии, а также триггеров прогрессирования этого опасного заболевания.
- 30 July 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
ОСОБЕННОСТИ ГИПЕРТОНИЧЕСКОЙ БОЛЕЗНИ У БЕРЕМЕННЫХ ЖЕНЩИН (ОБЗОР ЛИТЕРАТУРЫ)
Статья посвящена литературным данным об особенностях развития гипертонической болезни у беременных женщин. Около 11% случаев развития артериальной гипертонии верифицируется в группе беременных женщин. Клинические варианты артериальной гипертензии при беременности включают артериальную гипертензию, имевшуюся до беременности (хроническая артериальная гипертензия — гипертоническая болезнь или симптоматическая артериальная гипертензия), гестационную артериальную гипертонию, хроническую артериальную гипертензию, осложненную преэклампсией, и преэклампсию/эклампсию. Наиболее грозное осложнение гипертонической болезни у беременных – преэклампсия. В статье представлена классификация преэклампсии, принципы диагностики, профилактики и лечения этого осложнения. В статье так же отражены критерии классификации тяжести преэклампсии, возможность использования биохимических маркеров, с целью своевременного выявления рисков данного осложнения беременности, ранней профилактики, а так же обоснованного и адекватного лечения. Следует учитывать влияние преэклампсии на дальнейшую жизнь и здоровье женщины, так как доказано, что перенесенное осложнение беременности (преэклампсия) способствует, провоцирует или утяжеляет существующие ранее заболевания сердца и сосудов у матери и ребенка в будущем. Этим, в том числе, обусловлена немаловажная роль диспансерного наблюдения за беременными женщинами с артериальной гипертонией. Точной этиопатогенетической картины преэклампсии до сих пор нет, наиболее жизнеспособной является плацентарная теория развития преэклампсии, определяемая распространенным вазоспазмом, развитием эндотелиального воспаления и дисфункцией, а также прогрессирующей полиорганной недостаточностью. Несомненно, важной задачей остается своевременная диагностика, правильное лечении и предупреждение осложнений артериальной гипертензии у беременных. Показана необходимость и важность дальнейшего исследования этиологических факторов развития преэклампсии, а также триггеров прогрессирования этого опасного заболевания.
- Open Access
- 10 June 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (3S) , 5958
Pathogenesis and clinical significance of reperfusion arrhythmias in acute myocardial infarctio
The problem of ischemia-reperfusion injury, in particular, reperfusion arrhythmias, has remained controversial for many years. To date, there are no one frame of mind on the clinical and prognostic significance of tachyarrhythmias in the acute period of myocardial infarction. In addition, data on the incidence of reperfusion arrhythmias and related mortality are very contradictory. The review summarizes current concepts and results of studies devoted to the study of the clinical role of reperfusion arrhythmias. Their pathogenesis, structure, and impact on the long-term prognosis of patients are discussed. The need to study ischemia-reperfusion injury within the pharmacoinvasive strategy using modern thrombolytic agents is emphasized, which seems especially relevant given the Russian geographical features.
- 10 June 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (3S) , 5958
Open AccessPathogenesis and clinical significance of reperfusion arrhythmias in acute myocardial infarctio
The problem of ischemia-reperfusion injury, in particular, reperfusion arrhythmias, has remained controversial for many years. To date, there are no one frame of mind on the clinical and prognostic significance of tachyarrhythmias in the acute period of myocardial infarction. In addition, data on the incidence of reperfusion arrhythmias and related mortality are very contradictory. The review summarizes current concepts and results of studies devoted to the study of the clinical role of reperfusion arrhythmias. Their pathogenesis, structure, and impact on the long-term prognosis of patients are discussed. The need to study ischemia-reperfusion injury within the pharmacoinvasive strategy using modern thrombolytic agents is emphasized, which seems especially relevant given the Russian geographical features.
- Open Access
- 14 February 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (4) , 5800
Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
Aim. To study the effect of 48-week therapy with atorvastatin and ezetimibe on laboratory parameters, structural and functional arterial characteristics and heart failure markers in the post-infarction period.Material and methods. A total of 87 patients with acute myocardial infarction were included. In the first 24 hours, atorvastatin 80 mg/day was prescribed. During hospitalization, after 5-6, 24, 48 weeks, clinical and paraclinical examinations were performed. In the level of low-density lipoprotein cholesterol (LDL-C) >1,4 mmol/l and the decrease Results. Eighty participants (93%) completed the study. Patients were divided into following groups: group 1 (n=32) — atorvastatin monotherapy; group 2 (n=49) — ezetimibe and atorvastatin therapy. In group 1, LDL-C decreased after 48 weeks by 53% (pConclusion. The results rationale adding ezetimibe to statins in very high-risk patients due to the most pronounced lipid lowering effect, improvement of the structural and functional properties of the common carotid arteries, endothelial function and clinical and laboratory heart failure markers.
- 14 February 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (4) , 5800
Open AccessCombined lipid lowering therapy, including ezetimibe, in the post-infarction period
Aim. To study the effect of 48-week therapy with atorvastatin and ezetimibe on laboratory parameters, structural and functional arterial characteristics and heart failure markers in the post-infarction period.Material and methods. A total of 87 patients with acute myocardial infarction were included. In the first 24 hours, atorvastatin 80 mg/day was prescribed. During hospitalization, after 5-6, 24, 48 weeks, clinical and paraclinical examinations were performed. In the level of low-density lipoprotein cholesterol (LDL-C) >1,4 mmol/l and the decrease Results. Eighty participants (93%) completed the study. Patients were divided into following groups: group 1 (n=32) — atorvastatin monotherapy; group 2 (n=49) — ezetimibe and atorvastatin therapy. In group 1, LDL-C decreased after 48 weeks by 53% (pConclusion. The results rationale adding ezetimibe to statins in very high-risk patients due to the most pronounced lipid lowering effect, improvement of the structural and functional properties of the common carotid arteries, endothelial function and clinical and laboratory heart failure markers.
- Open Access
- 26 December 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (2) , 5738
Echocardiographic parameters of the left ventricle in patients after Q-wave and non-Q-wave myocardial infarction
Aim. To perform a dynamic assessment and comparative analysis of non-invasive parameters of myocardial function in patients with Q-wave and non-Q-wave myocardial infarction (MI) during 24-week follow-up after revascularization.Material and methods. A total of 95 patients with acute MI were included. On days 7-9 and after 24 weeks, speckle tracking echocardiography was performed with assessment of global longitudinal (GLS), global circumferential (GCS) and global radial strain (GRS), global work index (GWI), global constructive work (GCW), global wasted work (GWW), global work efficiency (GWE).Results. Taking into account the presence/absence of the Q wave, the subjects were divided into two groups: Q-wave MI — 66 patients (69,5%), non-Q-wave MI — 29 (30,5%) people. In the Q-wave MI group, by the 24th week, most parameters of myocardial performance were significantly lower than in the comparison group. In group 1, GWE was 93 (87; 96)% vs 96 (91; 97)% (p=0,04) in group 2; GWI — 1429±444,1 and 1653,3±385,84 mm Hg %, respectively (p=0,02). The GCW level in the Q-wave MI group was 1640±477,8 mm Hg % vs 1852,9±440,88 mm Hg % in the non-Q-wave MI group (p=0,04). Subsequently, a favorable increase in GLS (p=0,01), GWI (p=0,04), GWE (p=0,01), GCW (p=0,03) was revealed in the non-Q-wave MI group.Conclusion. The results obtained suggest that non-invasive parameters of myocardial performance can be used to assess transient ischemic dysfunction due to myocardial stunning, expressed to varying severity in patients with Q-wave MI and non-Q-wave MI.
- 26 December 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (2) , 5738
Open AccessEchocardiographic parameters of the left ventricle in patients after Q-wave and non-Q-wave myocardial infarction
Aim. To perform a dynamic assessment and comparative analysis of non-invasive parameters of myocardial function in patients with Q-wave and non-Q-wave myocardial infarction (MI) during 24-week follow-up after revascularization.Material and methods. A total of 95 patients with acute MI were included. On days 7-9 and after 24 weeks, speckle tracking echocardiography was performed with assessment of global longitudinal (GLS), global circumferential (GCS) and global radial strain (GRS), global work index (GWI), global constructive work (GCW), global wasted work (GWW), global work efficiency (GWE).Results. Taking into account the presence/absence of the Q wave, the subjects were divided into two groups: Q-wave MI — 66 patients (69,5%), non-Q-wave MI — 29 (30,5%) people. In the Q-wave MI group, by the 24th week, most parameters of myocardial performance were significantly lower than in the comparison group. In group 1, GWE was 93 (87; 96)% vs 96 (91; 97)% (p=0,04) in group 2; GWI — 1429±444,1 and 1653,3±385,84 mm Hg %, respectively (p=0,02). The GCW level in the Q-wave MI group was 1640±477,8 mm Hg % vs 1852,9±440,88 mm Hg % in the non-Q-wave MI group (p=0,04). Subsequently, a favorable increase in GLS (p=0,01), GWI (p=0,04), GWE (p=0,01), GCW (p=0,03) was revealed in the non-Q-wave MI group.Conclusion. The results obtained suggest that non-invasive parameters of myocardial performance can be used to assess transient ischemic dysfunction due to myocardial stunning, expressed to varying severity in patients with Q-wave MI and non-Q-wave MI.